CD4 and urinary bladder carcinoma: Finally, two recent reports showed that a cytotoxic CD4 T-cell gene signature was associated with immunotherapy response in bladder cancer [312] and that mismatch-repair deficient, MHC-I low tumors were highly infiltrated with CD4 T cells [313].